Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - RESEARCH & DEVELOPMENT
Research & Development RARE - Ultragenyx Pharmaceutical Inc.
698 M
LAST VALUE
-0.56%
2 YEAR CAGR
14.32%
5 YEAR CAGR
31.26%
10 YEAR CAGR